# Protective Effect in Cardiac Surgery Patients

> **NCT04028024** · NA · UNKNOWN · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Cardiac Surgery

## Interventions

- **DRUG:** Ulinastatin

## Key facts

- **NCT ID:** NCT04028024
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-01
- **Primary completion:** 2020-12
- **Final completion:** 2021-06
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2019-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04028024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04028024, "Protective Effect in Cardiac Surgery Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04028024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*